Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 30, 2023
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
[ Thu, Nov 30th 2023
] - WOPRAI
Wed, November 29, 2023
[ Wed, Nov 29th 2023
] - WOPRAI
Julian Harrison Initiated (AKBA) at Strong Buy and Held Target at $4 on, Nov 29th, 2023
Julian Harrison of BTIG, Initiated "Akebia Therapeutics, Inc." (AKBA) at Strong Buy and Held Target at $4 on, Nov 29th, 2023.
Julian has made no other calls on AKBA in the last 4 months.
There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Julian's Rating of Hold.
This is the rating of the analyst that currently disagrees with Julian
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $5 on, Friday, November 17th, 2023
